Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Keratosis, Actinic 5Lymphoma, T-Cell, Cutaneous 2Vascular Malformations 1Uterine Cervical Dysplasia 1Surgical Wound Infection 1Pilonidal Sinus 1Pancreatic Neoplasms 1Pain 1Mycosis Fungoides 1Keratosis 1High-grade Anal Intraepithelial Neoplasia 1Hemangioma, Capillary 1Hemangioma 1Head and Neck Neoplasms 1Dermatitis, Contact 1Condylomata Acuminata 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Cancer Lymphedema 1

Interventions

Exercise 5Exercise Therapy 3Manual Lymphatic Drainage 2Low-Level Light Therapy 2Indocyanine Green 2Gloves, Protective 2Compression Bandages 2tapasin 1carbohydrate-deficient transferrin 1Triamcinolone 1Tacrolimus 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Resistance Training 1Rehabilitation 1Physical Therapy Modalities 1Ointments 1Myofascial Release Therapy 1Muscle Stretching Exercises 1Methods 1Ketoprofen 1House Calls 1Fluid Therapy 1Diagnosis-Related Groups 1Bupivacaine 1Athletic Tape 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Lymphedema × Ointments × Clear all
NCT04541290 2022-02-09

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

Odense University Hospital

Phase 1/2 Completed
20 enrolled
Breast

Breast Cancer Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡